Sensei Biotherapeutics Inc (SNSE) concluded trading on Thursday at a closing price of $1.65, with 4.29 million shares of worth about $7.08 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 132.07% during that period and on May 02, 2024 the price saw a gain of about 30.95%. Currently the company’s common shares owned by public are about 25.03M shares, out of which, 16.29M shares are available for trading.
Stock saw a price change of 64.98% in past 5 days and over the past one month there was a price change of 66.67%. Year-to-date (YTD), SNSE shares are showing a performance of 138.44% which increased to 7.49% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.51 but also hit the highest price of $1.72 during that period. The average intraday trading volume for Sensei Biotherapeutics Inc shares is 81.64K. The stock is currently trading 60.50% above its 20-day simple moving average (SMA20), while that difference is up 67.32% for SMA50 and it goes to 89.47% higher than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Sensei Biotherapeutics Inc (NASDAQ: SNSE) currently have 25.03M outstanding shares and institutions hold larger chunk of about 11.02% of that.
The stock has a current market capitalization of $41.37M and its 3Y-monthly beta is at 0.10. It has posted earnings per share of -$1.21 in the same period. It has Quick Ratio of 11.92 while making debt-to-equity ratio of 0.10. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for SNSE, volatility over the week remained 19.61% while standing at 12.84% over the month.
Analysts are in expectations that Sensei Biotherapeutics Inc (SNSE) stock would likely to be making an EPS of $SenesTech, Inc. in the current quarter, while forecast for next quarter EPS is $0.86 and it is $Stocks for next year. For the current quarter EPS, analysts have given the company a lowest target $SNPE which is $VNSE at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of $Inspired Entertainment, Inc. in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 19.37% while it is estimated to decrease by -5.23% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Berenberg on July 01, 2021 offering a Hold rating for the stock and assigned a target price of $12 to it. Coverage by Oppenheimer stated Sensei Biotherapeutics Inc (SNSE) stock as a Perform in their note to investors on June 29, 2021, suggesting a price target of $14 for the stock. On March 01, 2021, Piper Sandler Initiated their recommendations, while on March 01, 2021, Oppenheimer Initiated their ratings for the stock with a price target of $36. Stock get a Buy rating from Citigroup on March 01, 2021.
